PRESS RELEASE published on 08/16/2023 at 07:00, 2 years 8 months ago Biophytis annonce les prochaines étapes règlementaires en Europe et aux Etats-Unis pour son projet COVA
PRESS RELEASE published on 08/08/2023 at 07:00, 2 years 9 months ago Biophytis receives a positive opinion for its SARA-31 phase 3 study in sarcopenia in Europe
PRESS RELEASE published on 08/08/2023 at 07:00, 2 years 9 months ago Biophytis obtient un avis positif pour son étude de phase 3 SARA-31 dans la sarcopénie en Europe
PRESS RELEASE published on 07/20/2023 at 07:00, 2 years 9 months ago Biophytis: Biophytis has requested a pre-submission meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the treatment of COVID-19
PRESS RELEASE published on 07/20/2023 at 07:00, 2 years 9 months ago Biophytis a requis auprès de la FDA une réunion de pré-soumission d’Autorisation d’Utilisation d’Urgence de Sarconeos (BIO101) dans le traitement du COVID-19
PRESS RELEASE published on 07/19/2023 at 07:53, 2 years 9 months ago Biophytis annonce un Placement Direct Enregistré de 3,8 millions de dollars
PRESS RELEASE published on 07/19/2023 at 07:53, 2 years 9 months ago Biophytis Announces $3.8 Million Registered Direct Offering
PRESS RELEASE published on 07/18/2023 at 07:00, 2 years 9 months ago Biophytis et SEQENS signent un partenariat pour la production du principe actif de Sarconeos (BIO101)
PRESS RELEASE published on 07/18/2023 at 07:00, 2 years 9 months ago Biophytis and SEQENS sign a partnership to produce Sarconeos (BIO101) active compound
PRESS RELEASE published on 07/10/2023 at 07:00, 2 years 9 months ago Biophytis has filed with the FDA for authorization to initiate SARA-31 phase 3 study in sarcopenia
Published on 05/09/2026 at 01:30, 4 hours 53 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 6 hours 23 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 9 hours 44 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 11 hours 10 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 11 hours 20 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 11 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 11 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 11 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 11 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 11 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
